Women with T1D and PCOS showed a tendency that was close to reaching statistical significance, to more frequently use continuous subcutaneous insulin infusion (CSII) and to have increased WHRs than those without PCOS, even though BMI was similar in both groups (Table 1). This evidence concerns the gene INS and polycystic ovary syndrome.